STVYX
Price
$20.89
Change
-$0.16 (-0.76%)
Updated
Sep 6 closing price
VVIAX
Price
$65.30
Change
-$0.84 (-1.27%)
Updated
Sep 6 closing price
Ad is loading...

STVYX vs VVIAX

Header iconSTVYX vs VVIAX Comparison
Open Charts STVYX vs VVIAXBanner chart's image
SEI Tax-Managed Mgd Volatility Y (SIMT)
Price$20.89
Change-$0.16 (-0.76%)
VolumeN/A
CapitalizationN/A
Vanguard Value Index Adm
Price$65.30
Change-$0.84 (-1.27%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
STVYX vs VVIAX Comparison Chart
Loading...
VS
STVYX vs. VVIAX commentary
Sep 08, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is STVYX is a Buy and VVIAX is a Buy.

FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 183B vs. STVYX (829M). VVIAX pays higher dividends than STVYX: VVIAX (2.36) vs STVYX (1.05). STVYX was incepted earlier than VVIAX: STVYX (9 years) vs VVIAX (24 years). STVYX is a more actively managed with annual turnover of: 22.00 vs. VVIAX (10.00). VVIAX has a lower initial minimum investment than STVYX: VVIAX (3000) vs STVYX (100000). VVIAX annual gain was more profitable for investors over the last year : 19.30 vs. STVYX (8.98). VVIAX return over 5 years is better than : 53.51 vs. STVYX (28.49).
STVYXVVIAXSTVYX / VVIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years24 years-
Gain YTD18.62513.506138%
Front LoadN/AN/A-
Min. Initial Investment10000030003,333%
Min. Initial Investment IRAN/AN/A-
Net Assets829M183B0%
Annual Yield % from dividends1.052.3644%
Returns for 1 year8.9819.3047%
Returns for 3 years4.4819.6823%
Returns for 5 years28.4953.5153%
Returns for 10 yearsN/A107.57-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GDYN14.080.47
+3.45%
Grid Dynamics Holdings
USEG0.910.01
+1.00%
US Energy Corp
BCE35.950.07
+0.20%
BCE
LNKB6.15N/A
N/A
LINKBANCORP
CRNX50.98-1.82
-3.45%
Crinetics Pharmaceuticals